Definitive Contract 75F40122C00127

Award Date 9/20/22
Potential Completion Date 9/19/26
Potential Value $3.4M
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Harrisburg, PA 17101, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $229,473.61 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the Executive Office of the Governor of Delaware, Division of Public Health, to conduct inspections of certified non-federal mammography facilities in Delaware. The contract is for five years, with a period of performance ending on August 31, 2027. The contract was awarded as a sole-source to the Division of Public Health, as it is the state entity that possesses the legal authority...
This is a definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency, to the Connecticut Department of Energy & Environmental Protection (DEEP). The contract, valued at $1,817,587.32, is for services related to the FDA's Mammography Quality Standards Act (MQSA) program, which regulates mammography facilities. The contract has a period of performance ending on September 29, 2027 and is a firm fixed-price contract. The contract was not set aside for any specific...
This is a firm-fixed price contract awarded by the Food and Drug Administration (FDA) to the Ohio Department of Health (ODH) to conduct Mammography Quality Standards Act (MQSA) inspections of certified non-federal mammography facilities in Ohio. The contract has a base year award value of $370,904.16 and a ceiling value of $1,928,987.04 over the 5-year period of performance through July 2027. The contract was awarded sole-source to ODH, as a state government organization with the legal authority...
This contract was awarded by the Food and Drug Administration (FDA) to the Arizona Department of Health Services (ADHS), a state government entity, to conduct inspections of certified non-federal mammography facilities in Arizona. The contract, valued at $1,911,936.08, is a definitive, firm-fixed-price contract with a period of performance through March 29, 2028. The original solicitation was a sole-source procurement, as the inspections require legal authority under state law and experience...
The U.S. Food and Drug Administration (FDA) awarded a $2,482,950.23 Firm Fixed Price contract to the Michigan Department of Labor and Economic Opportunity (MDLEO), doing business as the Talent Investment Agency, to implement the Mammography Quality Standards Act (MQSA). The contract, awarded without any set-aside designation, runs through March 2022 and requires MDLEO to provide specialized regulatory oversight and services to ensure the quality and safety of mammography facilities. As a state...
This is a definitive contract awarded by the U.S. Food and Drug Administration (FDA) to The Environment Maryland Department Of Office Of Fiscal Services Division, doing business as State Of Maryland, for $705,383.99. The contract is for Mammography Quality Standards Act (MQSA) inspections and does not have a set-aside designation. As the state environmental protection agency, The Environment Maryland Department is responsible for various environmental programs, monitoring activities, and...
This is a $201,505.99 firm fixed-price definitive contract awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to the Division of Public Health, which is part of the Executive Office of the Governor of Delaware. The contract is for mammography inspection services in the state of Delaware, as required under the Mammography Quality Standards Act. The Division of Public Health, as the public health authority for the state of Delaware, has previously provided...
The Washington State Department of Health was awarded a $1,177,784.02 firm-fixed-price contract by the Food and Drug Administration (FDA) to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). This is a sole-source award, as the contract is restricted to state organizations possessing the legal authority to access commercial establishments for regulatory inspections and experienced...
This is a federal contract award from the Food and Drug Administration (FDA) to the State of Maryland's Department of the Environment, Office of Fiscal Services Division. The contract, titled "MARYLAND MQSA", is a firm-fixed price definitive contract with a total ceiling value of $1,329,319.38 and a period of performance that runs through March 31, 2028. The contract does not have a set-aside designation. The contract requires the State of Maryland to provide environmental...
This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to the Massachusetts Department of Public Health, a U.S. state government entity, for Mass MQSA (Mammography Quality Standards Act) inspections. The contract has a firm fixed price pricing type and a potential value of $1,711,136.29. It was awarded on June 1, 2017 with a completion date of June 30, 2022. This contract is not associated with a larger vehicle and does not have a...

This is a sole source, definitive contract awarded by the Food and Drug Administration (FDA) to the Pennsylvania Department of Environmental Protection (DEP) to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract has a ceiling value of $3,364,865.52 and a period of performance through September 19, 2026.

The contract was awarded without a set-aside designation. It references a prior pre-solicitation notice indicating the FDA's intent to award sole source contracts to state organizations possessing the legal authority and experience necessary to perform the regulatory MQSA inspections. As the designated state agency in Pennsylvania with this specialized capability, DEP was awarded the contract. The contract provides the FDA with access to DEP's trained personnel, inspection procedures, and regulatory enforcement expertise to oversee compliance at mammography facilities across the state.

Generated 1/22/25, 9:02 AM